Sale!

RECQL Gene Breast Cancer Susceptibility NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The RECQL Gene Breast Cancer Susceptibility NGS Genetic DNA Test is a cutting-edge genetic screening that identifies mutations in the RECQL gene, which significantly increases breast cancer risk. This comprehensive test uses Next Generation Sequencing technology to detect inherited genetic variants with 99% accuracy. Individuals with family history of breast cancer, early-onset cases, or multiple affected relatives should consider this test. Benefits include early risk detection, personalized prevention strategies, and informed family planning decisions. The test costs $500 USD and provides results within 3-4 weeks using blood, extracted DNA, or FTA card samples. Genetic counseling is included to help interpret results and develop proactive health management plans.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

RECQL Gene Breast Cancer Susceptibility NGS Genetic DNA Test

Comprehensive Genetic Testing for Breast Cancer Risk Assessment

The RECQL Gene Breast Cancer Susceptibility NGS Genetic DNA Test represents a breakthrough in personalized cancer prevention and risk management. This advanced genetic screening utilizes Next Generation Sequencing (NGS) technology to identify mutations in the RECQL gene, which plays a crucial role in DNA repair and maintenance. When RECQL gene function is compromised, individuals face significantly elevated risks of developing breast cancer throughout their lifetime.

What Does This Test Measure and Detect?

Our sophisticated NGS-based test specifically targets and analyzes the RECQL gene for pathogenic variants that indicate increased breast cancer susceptibility. The test detects:

  • Point mutations and small insertions/deletions in the RECQL gene
  • Known pathogenic variants associated with hereditary breast cancer
  • Novel genetic alterations that may impact DNA repair mechanisms
  • Both inherited and de novo mutations affecting cancer risk

The RECQL gene encodes a DNA helicase enzyme essential for maintaining genomic stability. Mutations in this gene disrupt normal DNA repair processes, leading to accumulated genetic damage and increased cancer predisposition, particularly for breast cancer.

Who Should Consider This Genetic Test?

This comprehensive genetic screening is particularly recommended for individuals who meet any of the following criteria:

  • Personal history of breast cancer diagnosed before age 45
  • Family history of breast cancer in multiple generations
  • Presence of male breast cancer in the family
  • Individuals with bilateral breast cancer
  • Those with family history of other RECQL-associated cancers
  • Women with dense breast tissue and family cancer history
  • Individuals of ethnic backgrounds with higher RECQL mutation prevalence

Significant Benefits of RECQL Gene Testing

Undergoing RECQL gene testing provides numerous advantages for proactive health management:

  • Early Risk Identification: Detect genetic predisposition before cancer development
  • Personalized Screening Plans: Tailor mammogram frequency and additional imaging based on genetic risk
  • Informed Prevention Strategies: Implement targeted risk-reduction measures
  • Family Risk Assessment: Identify at-risk relatives who may benefit from testing
  • Reproductive Planning: Make informed decisions about family planning
  • Peace of Mind: Reduce uncertainty through definitive genetic information

Understanding Your Test Results

Our comprehensive genetic counseling service helps you interpret your results with clarity and confidence:

  • Positive Result: Indicates presence of a pathogenic RECQL mutation, requiring enhanced surveillance and preventive measures
  • Negative Result: No detected RECQL mutation, though continued routine screening is recommended
  • Variant of Uncertain Significance: Identified genetic change with unknown clinical impact, requiring ongoing monitoring
  • Professional Guidance: Our genetic counselors provide personalized recommendations based on your specific results

Test Pricing and Sample Requirements

Test Feature Details
Test Name RECQL Gene Breast Cancer Susceptibility NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card

Nationwide Availability and Booking

We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, and Philadelphia. Our state-of-the-art facilities ensure accurate testing and comprehensive genetic counseling services.

Take the first step toward proactive breast cancer risk management. Book your RECQL Gene Breast Cancer Susceptibility Test today by calling our genetic specialists at +1(267) 388-9828 or schedule your appointment online. Early detection through genetic testing can save lives and provide peace of mind for you and your family.

Pre-Test Preparation Requirements

To ensure optimal testing accuracy and comprehensive risk assessment, we require:

  • Complete clinical history documentation
  • Mandatory genetic counseling session
  • Detailed pedigree chart of family cancer history
  • Informed consent for genetic testing
  • Discussion of potential implications for family members

Our team of certified genetic counselors and oncology specialists work together to provide you with the most comprehensive breast cancer risk assessment available. Trust GGC DNA for accurate, reliable genetic testing that empowers you to take control of your health future.